Healthcare

US Autoimmune Disease Diagnostics Market, Forecast to 2020

Systemic Autoimmune Diseases to Spur Double-digit Market Growth as Participants Look to Unmet Needs and Game-changing Strategies to Boost Revenues

INDUSTRY
Healthcare

RELEASE DATE
24-Feb-2016
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
9AB9-00-48-00-00
SKU
HC02380-NA-MR_16502
Yes
SHARE

US Autoimmune Disease Diagnostics Market, Forecast to 2020
Published on: 24-Feb-2016 | SKU: HC02380-NA-MR_16502

Need more details?

$1,500.00

$1,125.00 save 25 %

DownloadLink
Need more details?

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as well as localized diseases, such as celiac, IBD, IBS, and Hashimoto's. Systemic diseases dominate the market due to their high prevalence in the United States and also because of the market participation of large diagnostics companies, such as Inova Diagnostics, Siemens Healthcare, Abbott Diagnostics, and Beckman Coulter. The localized disease segment is the fastest-growing, mainly due to celiac, as gluten intolerance in the United States is increasing at an exponential rate.

Scope and Segmentation

Key Predictions: US Autoimmune Disease Diagnostics Market

Current Trends in the Autoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market—Overview

Key Companies to Watch

Ecosystem of the Autoimmune Disease Diagnostics Market

Significance of the Autoimmune Disease Diagnostics Market

Significance of the Autoimmune Disease Diagnostics Market—Prevalence Rates

Competitive Landscape

Key Diseases and Available Solutions in the US Market

Key Diseases and Available Solutions in the US Market (continued)

LDTs—Role in Autoimmune Disease Diagnostics

Segment Lifecycle Analysis by Disease

Overall Market Forecast

Overall Disease Segment Share

Competitive SWOT Analysis by Company

Competitive SWOT Analysis by Company (continued)

Where do the Opportunities Lie in this Market?

Pharma and Diagnostics Business Integration

Autoimmune Diagnostics Companies are Uniting with Pharmaceuticals to Diversify Revenue Channels

Direct-to-Consumer Market: The Risk and The Opportunity

Localized Disease Diagnostics Segment Revenue

Growth Rate by Localized Autoimmune Diseases

Competitive Value Matrix—Localized Disease Diagnostics Segment

Autoimmune Tests—Role in Patient Continuum

Systemic Disease Diagnostics Segment Revenue

Growth Rate by Systemic Autoimmune Diseases

Competitive Value Matrix—Systemic Disease Diagnostics Segment

Autoimmune Tests—Role in Patient Continuum

Key Conclusions and Future Outlook

Legal Disclaimer

Celiac Disease-specific LDT Assays

Chron’s Disease-specific LDT Assays

RA-specific LDT Assays

Lupus-specific LDT Assays

IBD/IBS-specific LDT Assays

Others

Learn More—Next Steps

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

28 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Health Monitoring Wearable Solutions, 2026

The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...

26 Oct 2026   |   Global   |   Technology Research

Game-Changing Innovations Transforming Cardiovascular Care

The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.